Budiarto, A. Faktor risiko gangguan ginjal pada anak dengan leukemia limfoblastik akut yang mendapatkan protokol kemoterapi Indonesian protocol acute lymphoblastic leukemia (ALL) 2013 selama fase induksi dan konsolidasi. [dissertation]. Universitas Airlangga, Surabaya; 2019.

Belay Y, Yirdaw K, Enawgaw B. Tumor lysis syndrome in patients with hematological malignancies. J Oncol 2017;2017:9684909. doi: 10.1155/2017/9684909.

Russell TB, Kram DE. Tumor lysis syndrome. Pediatr Rev 2020;41:20–6. doi: 10.1542/pir.2018-0243.

Naeem B, Moorani KN, Anjum M, Imam U. Tumor lysis syndrome in pediatric acute lymphoblastic leukemia at tertiary care center. Pak J Med Sci 2019;35:899-904. doi: 10.12669/pjms.35.4.715.

Xue Y, Chen J, Gao S, et al. Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia. Sci Rep 2021;11:1–9. doi: 10.1038/s41598-021-88912-2.

Cheung WL, Hon KL, Fung CM, Leung AK. Tumor lysis syndrome in childhood malignancies. Drugs in context 2020:9:2019-8-2. doi: 10.7573/dic.2019-8-2

Bahoush GR, Yazdi E, Ansari SH, Arjmandi KH, Vossough P. Identification of children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome. J Blood Disord Transfus 2015;6:6. doi: 10.4172/2155-9864.1000318

Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010;149:578-86. doi:10.1111/j.1365-2141.2010.08143.x

Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004;127:3–11. doi: 10.1111/j.1365-2141.2004.05094.x.

Atri SK, Devi E, Homdutt Kumar S, Singh BP. Prevalence of tumor lysis syndrome in acute leukemia and lymphoreticular malignancies: a regional study from PGIMS, Rohtak. J Med Sci Clin Res 2021:9;72-80. doi: 10.18535/jmscr/v9i3.16.

Alakel N, Middeke JM, Schetelig J, Bornhäuser M. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. Onco Targets Ther 2017;10:597-605. doi:10.2147/OTT.S103864.

Ajmal MU, Saleem R, Saad Ur Rehman SU, Arslan M, Malik I. Spontaneous tumor lysis syndrome in pediatric patients: a case series. Anaesth Pain Intensive Care 2024;28:372−5; doi: 10.35975/apic.v28i2.2409 .

Mansoor R, Saeed H, Wali RM, Rehman P, Abubakar M. Malnutrition, sepsis, and tumor lysis syndrome are associated with increased rate of acute mortality in mature B cell non-Hodgkin lymphoma in a pediatric population - study from tertiary care hospital in Pakistan. Mediterr J Hematol Infect Dis 2019;11:1–7. doi: 10.4084/MJHID.2019.043.

Jones GL, Will A, Jackson GH, Webb NJA, Rule S. Guidelines for managing tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol 2015;169:661–71. doi: 10.1111/bjh.13403.

Hesham AAB, Eman NE, Azza AE, Almontaser MH. Clinical and laboratory approach for the identification of the risk for tumour lysis syndrome in children with acute lymphoblastic leukemia. Life Science J 2012; 9:189-95.

Elkhatib LH, Bayoumy MS, Ahmed AM, Alam MM, Abosoudah IF, Altrabolsi HA. Tumor lysis syndrome in pediatric patients with hematological malignancies. J Appl Hematol 2022;13:118-25. doi: 10.4103/joah.joah_243_20

Arnaud M, Loiselle M, Vaganay C, et al. Tumor lysis syndrome and AKI: beyond crystal mechanisms. J Am Soc Nephrol 2022;33:1154-71. doi:10.1681/ASN.2021070997

Lupusoru G, Ailincai I, Fratila G, et al. Tumor lysis syndrome: an endless challenge in onco-nephrology. Biomedicines 2022;10:1012. doi: 10.3390/biomedicines10051012

Sury, K. Update on the prevention and treatment of tumor lysis syndrome. J Onco-Nephrol 2019;3:19–30. doi: 10.1177/2399369319837212.

Hariharan U, Natarajan V. Critical care management and newer therapies for tumour lysis syndrome. J Blood Lymph 2017;7:189. doi: 10.4172/2165-7831.1000189.